We reviewed 78 femoral and tibial nonunions treated between January 1992 and December 2003. Of these, we classified 41 in 40 patients as complex cases because of infection (22), bone loss (6) or failed previous surgery (13). The complex cases were all treated with Ilizarov frames. At a mean time of 14.1 months (4 to 38), 39 had healed successfully.
The senior author (RM) has been using the Ilizarov technique to treat nonunion of fractures for more than 15 years. It allows the use of compression, distraction, bone lengthening and correction of deformity, but because it is labour intensive its use is not widespread. Many tibial and femoral nonunions can be treated satisfactorily by internal fixation 1, 2 with or without bone grafting. However, infection, bone exposure, bone loss, deformity or failure of previous internal fixation are relative contraindications to internal fixation. In these more complicated cases, which we define as complex nonunions, the Ilizarov method is particularly valuable. The choice in such patients may be between limb salvage using the Ilizarov method and amputation.
It is important to evaluate the outcome and cost of this treatment in view of the considerable investment in time and resources by both the patient and the health service. To our knowledge, no previous studies evaluating the costs involved in treating complex nonunion have been published in the United Kingdom. The aim of this study was to assess the functional and radiological outcome in patients with complex femoral and tibial nonunion treated by the Ilizarov technique, as well as the costs involved.
Patients and Methods
We defined complex nonunion as an established nonunion (of at least six months in duration) with one or more of the following criteria: infection at the site of nonunion; a bone defect of more than 4 cm (defect nonunion); an attempt to achieve union that failed to heal after at least one supplementary intervention, for example, bone grafting or exchange nailing.
We retrospectively identified patients who had undergone Ilizarov treatment for femoral or tibial nonunion using theatre lists and appointment diaries. The notes and radiographs of these patients were reviewed and those who met the above criteria for complex nonunion were included in the study. The mechanism of initial injury, number of previous operations, and the method of internal or external fixation were noted. Infected nonunions were classified according to whether the infection was active or quiescent, and the amount of bone loss. 3 Between January 1992 and December 2003, 78 patients were treated for femoral and tibial nonunion at our institution. Of these, 40 patients (41 nonunions) met the criteria for complex nonunion and were included in the study; of which 22 nonunions had an infection Trauma and the remaining 19 were not infected, but satisfied at least one other criterion (Table I) .
There were 35 males and five females, with a mean age of 41 years (10 to 73). There were six proximal tibial nonunions, 25 tibial shaft nonunions, five distal tibial nonunions and five femoral shaft nonunions. Of the patients 30 (75%) had been referred from other hospitals. Of the 41 nonunions, 21 had initially had an open fracture. Of these, six were grade 1, four were grade 2 and 11 were grade 3 according to the Gustilo-Anderson system. 4 The mechanism of the initial injury was a road traffic accident in 24 nonunions, a fall from a height in 12, an industrial accident in three and a sports injury in two.
The mean number of operations undergone by each patient prior to referral was three (1 to 10). There were 15 fractures treated initially by plating, 14 by external fixation, six by plaster cast and six by intramedullary nailing. Of these, two patients developed nonunion in an Ilizarov frame which was applied as primary treatment for the fracture and two who had their fractures plated after intramedullary fixation were referred to us after the plates had failed.
Infected nonunions were referred at a mean of 15.9 months (6 to 96) after the original fracture, whereas noninfected nonunions were referred at a mean of 25.6 months (6 to 168). Despite being warned that smoking might delay bone healing, 19 of the 40 patients continued to smoke during treatment. Of the 40 patients, 14 had received nonsteroidal anti-inflammatory drugs (NSAIDs) at some stage during treatment of their original fracture. Three patients were addicted to alcohol and required detoxification on admission.
A bifocal compression distraction technique (compression of the nonunion with distraction at the corticotomy) was used in 20 nonunions. Monofocal treatment (simple stabilisation of the nonunion with compression and stimulation of union by distraction) was used in 21 nonunions. 5 Bone grafting was undertaken in 28 cases, bone morphogenic protein (BMP-7) was used in six, ultrasound in nine and electromagnetic induction in two cases. Some cases had more than one of these treatments.
At final follow-up an independent assessor (SP) not involved in the treatment assessed the patients for gait, limb-length discrepancy and range of movement of the adjacent joints. Functional and radiological outcomes were assessed using the Association for the Study and Application of Methods of Ilizarov (ASAMI) criteria described by Paley et al. 6 In order to assess patient satisfaction, we used a visual analogue scale from 0 to 100, with 0 being completely unsatisfied and 100 being completely satisfied. This method was used by Sanders et al. 7 Our definition of union was the presence of bridging trabeculae on three cortices, absence of pain on dynamisation and absence of movement at the union site when screened using fluoroscopy. The cost of treatment was calculated for each patient using the estimate for the year 2004-2005 provided by the Finance Department of our hospital.
Results
The final functional outcome could not be assessed in eight patients. Of these, one had died of unrelated causes, one had developed dementia, four had moved and could not be contacted and two had an amputation. The mean follow-up time for the remaining 32 patients (33 cases) was 61.1 months (18 to 138) after removal of the frame. The bone results were calculated for all 40 patients (41 cases).
Of the 41 nonunions, 39 healed successfully, and the mean time to union was 14.1 months (4 to 38). There were two patients with persistent nonunion of the tibia who required below-knee amputation. The mean patient satisfaction score on a numerical scale 7 from 0 to 100 was 92. All but two patients said that they would undergo Ilizarov treatment if they were to suffer from a similar condition again. Of the 32 patients (33 nonunions) with successful treatment and a complete follow-up, seven did not work before or after treatment. A further 18 did not return to work after successful treatment, and only seven were able to return to work. No walking aid was required in 15, a walking stick was used by 13 patients, two patients used one crutch and two patients required two crutches.
We classified the adverse effects of our treatment as problems, obstacles and true complications (Table II) .
Two patients developed chronic osteomyelitis and one developed a septic ankle joint as the nonunion was in close proximity. He later required ankle fusion. One patient developed an infection adjacent to a broken tap, left behind during the first operation at the referring hospital.
Our results using the ASAMI criteria for outcome of nonunion are shown in Table III .
There were six poor bone results, two of which were refractures, two failed to unite and two united with other adverse factors. Both refractures were treated and subse- quently achieved an excellent radiological and functional result. We did not consider patients who required bone grafting to be a poor result. 5, 8 There were two patients with a poor functional result, one of whom had a below-knee amputation on the opposite side and a fracture of the seventh thoracic vertebra without a neurological deficit. The main reason for his inactivity was back pain. The other had an established compartment syndrome from the initial fracture with a foot drop and an equinus contracture, which required correction using the Ilizarov frame.
The bone and functional outcomes were not always the same. In seven patients the functional outcome was better than the bone outcome, whereas in five patients the bone outcome was better than the functional outcome.
The mean number of days in hospital for each patient was 47 (9 to 171). Two patients were in hospital for more than 100 days. One of these was a child aged 10 years at the start of treatment, with defect nonunion, whose prolonged stay was due to social problems. The mean number of outpatient appointments was 18 (2 to 52) ( Table IV) .
The mean cost of hospital treatment and various operations after the application of the frame was £23 604 per patient. If the cost of implants, radiological investigations, drugs and physiotherapy are also added, the cost per patient rose to approximately £30 000. This excludes the cost of bone morphogenetic protein and ultrasound (Table V) .
Discussion
Complex nonunions pose a formidable challenge to both surgeon and patient. The Ilizarov treatment has been successful in managing most problems in these patients, but it is not a panacea. There were two patients referred to us with complex nonunion who had developed it during primary treatment of their fracture with an Ilizarov frame. In addition, ten patients had a CT scan at £142/scan, totalling £35.50/patient. This cost excludes the cost of bone morphogenetic protein, ultrasound, electromagnetic induction and antibiotics Judging fracture union is not always straightforward. Despite using stringent criteria we had two cases where we felt that the nonunion had healed when it had not. Of the nonunions referred to us, three had previously been discharged by the treating surgeon as 'united'. In all these cases the nonunions were close to joints, similar to the experience reported by Marsh et al. 9 We have found CT scans helpful in the assessment of peri-articular nonunion when healing is in doubt.
The ASAMI outcome measurement divides the results into bone and functional. Several authors have used this system (Table VI) . [5] [6] [7] [8] 10 In all these papers, none of which are from the UK, the percentage of patients returning to work was fairly high. In comparison, 18 of our 32 patients available for functional assessment (56%) did not return to work. We think this was influenced by the following factors: Delay in referral. Infected nonunions were referred after a mean of 15.9 months (6 to 96), whereas non-infected nonunions were referred after a mean of 25.6 months (6 to 168). If the mean time for treatment is 14.1 months, and further rehabilitation time is at least three months, these patients are out of the labour market for more than 2.5 years for infected fractures and 3.25 years for uninfected fractures. Earlier referral could reduce this period. We recommend that all patients with complex nonunion of femoral and tibial fractures should be referred to a limb reconstruction centre by six months after injury. Social benefits and compensation. All 18 patients who lost employment were on disability or incapacity benefits. Some received large compensation awards. Two of our patients commented that they 'did not bother to look for work'. Therefore using employment as a benchmark for assessing functional outcome may not necessarily reflect the true outcome, particularly in countries where people receive substantial unemployment and incapacity benefits. Severity of injury or associated injury. At the start of this study, the senior author (RM) was the only surgeon using this method in a population of 2.6 million (north-east of England). Patients were generally referred when other methods could not be used or had already failed.
The overall outcome is affected by associated injuries. Often the result of the nonunion is satisfactory, but the patient's activities are restricted by the associated injuries. Those patients may need some assistance in their daily activities and would hence be classed as poor according to the ASAMI system.
As an example, a 47-year-old man with an eight-year-old infected nonunion of the right proximal femur was referred to us. He had a hip disarticulation on the other side from the original injury. The nonunion healed in an Ilizarov frame. He required some help in daily activities because of the contralateral hip disarticulation. The functional outcome was classed as a poor result using the original ASAMI system, as he lost his job, but the patient's satisfaction assessment was 100% (Fig. 1) .
Patient satisfaction is of paramount importance. Marsh et al 9 quoted a median patient satisfaction score of 6.5 of 7 (where 0 was not satisfied and 7 was completely satisfied). In this series, the mean patient satisfaction score was 92 on a scale of 0 to 100, where 0 was not satisfied and 100 was completely satisfied.
In view of the above-mentioned shortcomings, we propose two modifications to the ASAMI system. First, using patient satisfaction instead of employment as a benchmark for functional outcome. A patient who is unable to carry out daily activities because of the nonunion and who has a patient satisfaction score of less than 50 on a visual analogue scale would be deemed to have a poor result. We do not think that employment is a direct marker of functional outcome, as it is influenced by so many social factors. Secondly, a re-fracture does not necessarily imply an inferior result if union is subsequently achieved. In our two cases an excellent functional result was achieved. Re-fracture is a problem but not ultimately a complication in the long term if union is achieved.
Most complex nonunions end up in large centres. At present, in the United Kingdom there is no system of reimbursement to adequately support limb reconstruction in these centres. We hope that our cost data will help clinicians and managers resolve this. The results in our view justify the costs of this treatment. Williams 11 reported the average cost of treatment for limb reconstruction of tibial nonunions using the Ilizarov method to be $59 213 (approx. £33 752), which is similar to our costs. Despite this, the results are satisfying both for the patient and for the surgeon.
Supplementary Material
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